The document discusses current issues with implantable devices, such as poor tissue adhesion, bio-compatibility, and the risk of infection, proposing nanowire assemblies as a solution to enhance tissue growth, reduce complications, and improve anchoring. Specifically, titanium dioxide (TiO2) nanowires can replace traditional mechanical anchoring, providing anti-bacterial properties and better integration with tissue. This novel approach is applicable to devices like pain management implants and endovascular stent-grafts, aiming to increase reliability and lower surgery-related costs.